SLC9A5 and central nervous system cancer: In future studies, it is important to investigate whether NHE5 expression is upregulated in pathological samples obtained from glioma patients, and identify whether there are any correlations between NHE5 expression and pathological type, prognosis, and other glioma-associated factors.